Key aspects in nanotechnology and drug delivery

Nanotechnology and Drug Delivery: Volume 1: Nanoplatforms in Drug Delivery

Volumn , Issue , 2014, Pages 1-27

  Arias, José L ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DOSAGE; MEDICAL NANOTECHNOLOGY; MOLECULES; TARGETED DRUG DELIVERY;

DRUG ADVERSE EFFECTS; DRUG CONCENTRATION; DRUG DOSAGE FORM; ESSENTIAL ELEMENTS; FUNCTIONALIZATIONS; NANOPARTICULATE DRUG DELIVERY SYSTEMS; NANOPARTICULATE SYSTEM; THERAPEUTIC MOLECULES;

CONTROLLED DRUG DELIVERY;

EID: 84945891981     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17271     Document Type: Chapter

References (160)

1. Adibkia, K. and M.R. Siahi Shadbad, A. Nokhodchi, A. Javadzedeh, M. Barzegar-Jalali, J. Barar, G. Mohammadi and Y. Omidi. 2007. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J. Drug. Target. 15: 407-416.
2. Amiri, H. and K. Saeidi, P. Borhani, A. Manafi rad, M. Ghavami and V. Zerbi. 2013. Alzheimer’s disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem. Neurosci. 4: 1417-1429.
3. Andresen, T.L. and S.S. Jensen, T. Kaasgaard and K. Jørgensen. 2005. Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr. Drug Deliv. 2: 353-362.
4. Arias, J.L. 2008. Novel strategies to improve the anticancer action of 5-fl uorouracil by using drug delivery systems. Molecules. 13: 2340-2369.
5. Arias, J.L. Micro-and nano-particulate drug delivery systems for cancer treatment. pp. 1-85. In: P. Spencer and W. Holt [eds.]. 2009. Anticancer Drugs: Design, Delivery and Pharmacology. Nova Science Publishers, Inc., New York, USA.
6. Arias, J.L. 2010. Drug Targeting by Magnetically Responsive Colloids. Nova Science Publishers, Inc., New York, USA.
7. Arias, J.L. 2011a. Drug targeting strategies in cancer treatment: an overview. Mini Rev. Med. Chem. 11: 1-17.
8. Arias, J.L. 2011b. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin. Drug Deliv. 8: 1589-1608.
9. Arias, J.L. Nano-strategies in the delivery of antitumor drugs to cancer. pp. 268-289. In: R. Srirajaskanthan and V.R. Preedy [eds.]. 2012. Nanomedicine and Cancer. Science Publishers, New Hampshire, USA.
10. Arias, J.L. 2013. Liposomes in drug delivery: a patent review (2007-present). Expert Opin. Ther. Pat. 23: 1399-1414.
11. Arias, J.L. and L.H. Reddy and P. Couvreur. 2009a. Polymeric nanoparticulate system augmented the anticancer therapeutic effi cacy of gemcitabine. J. Drug Target. 17: 586-598.
12. Arias, J.L. and M. López-Viota, J. López-Viota and A.V. Delgado. 2009b. Development of iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. Int. J. Pharm. 382: 270-276.
13. Arias, J.L. and M. López-Viota, E. Sáez-Fernández and M.A. Ruiz. 2010. Formulation and physicochemical characterization of poly(epsilon-caprolactone) nanoparticles loaded with ftorafur and diclofenac sodium. Colloids Surf. B Biointerfaces. 75: 204-208.
14. Arias, J.L. and L.H. Reddy, M. Othman, B. Gillet, D. Desmaële, F. Zouhiri, F. Dosio, R. Gref and P. Couvreur. 2011a. Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. ACS Nano. 5: 1513-1521.
15. Arias, J.L. and L.H. Reddy and P. Couvreur. 2011b. Superior preclinical effi cacy of gemcitabine developed as chitosan nanoparticulate system. Biomacromolecules. 12: 97-104.
16. Arias, J.L. and G. Cebrián-Torrejón, E. Poupon, A. Fournet and P. Couvreur. 2011c. Biodegradable polymeric nanoformulation based on the antiprotozoal canthin-6-one. J. Nanopart. Res. 13: 6737-6746.
17. Arora, S. and S. Gupta, R.K. Narang and R.D. Budhiraja. 2011. Amoxicillin loaded chitosanalginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori. Sci. Pharm. 79: 673-694.
18. Ayano, E. and M. Karaki, T. Ishihara, H. Kanazawa and T. Okano. 2012. Poly(Nisopropylacrylamide)-PLA and PLA blend nanoparticles for temperature-controllable drug release and intracellular uptake. Colloids Surf. B Biointerfaces. 99: 67-73.
19. Bagre, A.P. and K. Jain and N.K. Jain. 2013. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Int. J. Pharm. 456: 31-40.
20. Barraud, L. and P. Merle, E. Soma, L. Lefrançois, S. Guerret, M. Chevallier, C. Dubernet, P. Couvreur, C. Trépo and L. Vitvitski. 2005. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42: 736-743.
21. Cao, J. and S. Huang, Y. Chen, S. Li, X. Li, D. Deng, Z. Qian, L. Tang and Y. Gu. 2013. Near-infrared light-triggered micelles for fast controlled drug release in deep tissue. Biomaterials. 34: 6272-6283.
22. Cattaneo, A.G. and R. Gornati, E. Sabbioni, M. Chiriva-Internati, E. Cobos, M.R. Jenkins and G. Bernardini. 2010. Nanotechnology and human health: risks and benefi ts. J. Appl. Toxicol. 30: 730-744.
23. Chen, T. and T. Zhao, D. Wei, Y. Wei, Y. Li and H. Zhang. 2013a. Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticle for tumor-targeted drug delivery. Carbohydr. Polym. 92: 1124-1132.
24. Chen, Y. and Z. Yang, C. Liu, C. Wang, S. Zhao, J. Yang, H. Sun, Z. Zhang, D. Kong and C. Song. 2013b. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Int. J. Nanomedicine. 8: 4315-4326.
25. Cheng, F.F. and J.J. Zhang, F. Xu, L.H. Hu, E.S. Abdel-Halim and J.J. Zhu. 2013. pH-sensitive polydopamine nanocapsules for cell imaging and drug delivery based on folate receptor targeting. J. Biomed. Nanotechnol. 9: 1155-1163.
26. Clares, B. and M.A. Ruiz, V. Gallardo and J.L. Arias. 2012. Drug delivery to infl ammation based on nanoparticles surface decorated with biomolecules. Curr. Med. Chem. 19: 3203-3211.
27. Clares, B. and R.A. Biedma-Ortiz, E. Sáez-Fernández, J.C. Prados, C. Melguizo, L. Cabeza, R. Ortiz and J.L. Arias. 2013. Nano-engineering of 5-fl uorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer. Eur. J. Pharm. Biopharm. 85: 329-338.
28. Couvreur, P. 2013. Nanoparticles in drug delivery: past, present and future. Adv. Drug Deliv. Rev. 65: 21-23.
29. Cowger, T. and J. Xie. 2013. Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging. Methods Mol. Biol. 1025: 225-235.
30. Cui, Y. and Q. Xu, P.K. Chow, D. Wang and C.H. Wang. 2013. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment. Biomaterials. 34: 8511-8520.
31. Dadashzadeh, S. and A.M. Vali and M. Rezaie. 2008. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Int. J. Pharm. 353: 251-259.
32. De Giglio, E. and A. Trapani, D. Cafagna, L. Sabbatini and S. Cometa. 2011. Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization. Anal. Bioanal. Chem. 400: 1997-2002.
33. Di Mascolo, D. and C.J. Lyon, S. Aryal, M.R. Ramirez, J. Wang, P. Candeloro, M. Guindani, W.A. Hsueh and P. Decuzzi. 2013. Rosiglitazone-loaded nanospheres for modulating macrophage-specifi c infl ammation in obesity. J. Control. Release. 170: 460-468.
34. Ding, H. and F. Wu. 2012. Image guided biodistribution of drugs and drug delivery. Theranostics. 2: 1037-1039.
35. Ditto, A.J. and K.N. Shah, N.K. Robishaw, M.J. Panzner, W.J. Youngs and Y.H. Yun. 2012. The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological fl ow. Mol. Pharm. 9: 3089-3098.
36. Dusinska, M. and Z. Magdolenova and L.M. Fjellsbø. 2013. Toxicological aspects for nanomaterial in humans. Methods Mol. Biol. 948: 1-12.
37. Ehmann, F. and K. Sakai-Kato, R. Duncan, D. Hernán Pérez de la Ossa, R. Pita, J.M. Vidal, A. Kohli, L. Tothfalusi, A. Sanh, S. Tinton, J.L. Robert, B. Silva Lima and M.P. Amati. 2013. Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines. Nanomedicine (Lond.). 8: 849-856.
38. El-Ansary, A. and S. Al-Daihan, A.B. Bacha and M. Kotb. 2013. Toxicity of novel nanosized formulations used in medicine. Methods Mol. Biol. 1028: 47-74.
39. Esmaeilia, F. and R. Dinarvand, M.H. Ghahremani, S.N. Ostad, H. Esmaily and F. Atyabi. 2010. Cellular cytotoxicity and in vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles. Anticancer Drugs. 21: 43-52.
40. Esposito, E. and M. Fantin, M. Marti, M. Drechsler, L. Paccamiccio, P. Mariani, E. Sivieri, F. Lain, E. Menegatti, M. Morari and R. Cortesi. 2008. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25: 1521-1530.
41. Fahmi, A. and D. Appelhans, N. Cheval, T. Pietsch, C. Bellmann, N. Gindy and B. Voit. 2011. Hybrid nanoalloy: nanofi bers fabricated by self-assembling dendrimers mediate in situ CdSe quantum dots and their metallization with discrete gold nanoparticles. Adv. Mater. 23: 3289-3293.
42. Feng, L. and C. Zhu, H. Yuan, L. Liu, F. Lv and S. Wang. 2013. Conjugated polymer nanoparticles: preparation, properties, functionalization and biological applications. Chem. Soc. Rev. 42: 6620-6633.
43. Fleige, E. and M.A. Quadir and R. Haag. 2012. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications. Adv. Drug Deliv. Rev. 64: 866-884.
44. Fontana, G. and M. Licciardi, S. Mansueto, D. Schillaci and G. Giammona. 2001. Amoxicillinloaded polyethylcyanoacrylate nanoparticles: infl uence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials. 22: 2857-2865.
45. Fonte, P. and F. Andrade, F. Araújo, C. Andrade, Jd. Neves and B. Sarmento. 2012. Chitosancoated solid lipid nanoparticles for insulin delivery. Methods Enzymol. 508: 295-314.
46. Gamal-Eldeen, A.M. and S.M. El-Daly, I.H. Borai, H.A. Wafay and A.R. Abdel-Ghaffar. 2013. Photodynamic therapeutic effect of indocyanine green entrapped in polymeric nanoparticles and their anti-EGFR-conjugate in skin cancer in CD1 mice. Photodiagnosis Photodyn. Ther. 10: 446-459.
47. Gong, C. and Y. Xie, Q. Wu, Y. Wang, S. Deng, D. Xiong, L. Liu, M. Xiang, Z. Qian and Y. Wei. 2012. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Nanoscale. 4: 6004-6017.
48. Guo, Y. and Z. Zhang, D.H. Kim, W. Li, J. Nicolai, D. Procissi, Y. Huan, G. Han, R.A. Omary and A.C. Larson. 2013. Photothermal ablation of pancreatic cancer cells with hybrid ironoxide core gold-shell nanoparticles. Int. J. Nanomedicine. 8: 3437-3446.
49. Hasan, A.A. and H. Madkor and S. Wageh. 2013. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. 20: 120-126.
50. Hashida, N. and N. Ohguro, N. Yamazaki, Y. Arakawa, E. Oiki, H. Mashimo, N. Kurokawa and Y. Tano. 2008. High-effi cacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome. Exp. Eye Res. 86: 138-149.
51. Heidari Majd, M. and D. Asgari, J. Barar, H. Valizadeh, V. Kafi l, A. Abadpour, E. Moumivand, J.S. Mojarrad, M.R. Rashidi, G. Coukos and Y. Omidi. 2013. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer. Colloids Surf. B Biointerfaces. 106: 117-125.
52. Hillaireau, H. and T. Le Doan, M. Besnard, H. Chacun, J. Janin and P. Couvreur. 2006. Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules. Int. J. Pharm. 324: 37-42.
53. Holgado, M.A. and L. Martin-Banderas, J. Alvarez-Fuentes, M. Fernandez-Arevalo and J.L. Arias. 2012. Drug targeting to cancer by nanoparticles surface functionalized with special biomolecules. Curr. Med. Chem. 19: 3188-3195.
54. Honary, S. and P. Ebrahimi and R. Hadianamrei. 2013. Optimization of size and encapsulation effi ciency of 5-fu loaded chitosan nanoparticles by response surface methodology. Curr. Drug Deliv. 10: 742-752.
55. Huynh, N.T. and E. Roger, N. Lautram, J.P. Benoît and C. Passirani. 2010. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine (Lond.). 5: 1415-1433.
56. Ibsen, S. and M. Benchimol, D. Simberg, C. Schutt, J. Steiner and S. Esener. 2011. A novel nested liposome drug delivery vehicle capable of ultrasound triggered release of its payload. J. Control. Release. 155: 358-366.
57. Ilie, I. and R. Ilie, T. Mocan, F. Tabaran, C. Iancu and L. Mocan. 2013. Nicotinamidefunctionalized multiwalled carbon nanotubes increase insulin production in pancreatic beta cells via MIF pathway. Int. J. Nanomedicine. 8: 3345-3353.
58. Ishida, T. and H. Kiwada. 2008. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int. J. Pharm. 354: 56-62.
59. Iyer, A.K. and A. Singh, S. Ganta and M.M. Amiji. 2013. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Deliv. Rev. 65: 1784-1802.
60. Jain, S. and A.S. Doshi, A.K. Iyer and M.M. Amiji. 2013. Multifunctional nanoparticles for targeting cancer and infl ammatory diseases. J. Drug Target. 21: 888-903.
61. Jana, U. and A.K. Mohanty, P.K. Manna and G.P. Mohanta. 2013. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100. Colloids Surf. B Biointerfaces. 113C: 269-275.
62. Janib, S.M. and A.S. Moses and J.A. MacKay. 2010. Imaging and drug delivery using theranostic nanoparticles. Adv. Drug Deliv. Rev. 62: 1052-1063.
63. Jiang, B. and L. Hu, C. Gao and J. Shen. 2005. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties. Int. J. Pharm. 304: 220-230.
64. Johnston, H. and G. Pojana, S. Zuin, N.R. Jacobsen, P. Møller, S. Loft, M. Semmler-Behnke, C. McGuiness, D. Balharry, A. Marcomini, H. Wallin, W. Kreyling, K. Donaldson, L. Tran and V. Stone. 2013. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit. Rev. Toxicol. 43: 1-20.
65. Joshi, H.M. and D.R. Bhumkar, K. Joshi, V. Pokharkar and M. Sastry. 2006. Gold nanoparticles as carriers for effi cient transmucosal insulin delivery. Langmuir. 22: 300-305.
66. Kaimal, V. and Z. Chu, Y.Y. Mahller, B. Papahadjopoulos-Sternberg, T.P. Cripe, S.K. Holland and X. Qi. 2011. Saposin C coupled lipid nanovesicles enable cancer-selective optical and magnetic resonance imaging. Mol. Imaging Biol. 13: 886-897.
67. Kanasty, R. and J.R. Dorkin, A. Vegas and D. Anderson. 2013. Delivery materials for siRNA therapeutics. Nat. Mater. 12: 967-977.
68. Kaur, K. and S. Jain, B. Sapra and A.K. Tiwary. 2007. Niosomal gel for site-specifi c sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Curr. Drug Deliv. 4: 276-282.
69. Kim, D. and Y.Y. Jeong and S. Jon. 2010. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano. 4: 3689-3696.
70. Kim, K.M. and J.H. Kang, A. Vinu, J.H. Choy and J.M. Oh. 2013. Inorganic nanomedicines and their labeling for biological imaging. Curr. Top. Med. Chem. 13: 488-503.
71. Kimbrell, G.A. 2009. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract. J. Law Med. Ethics. 37: 706-723.
72. Kono, K. and S. Nakashima, D. Kokuryo, I. Aoki, H. Shimomoto, S. Aoshima, K. Maruyama, E. Yuba, C. Kojima, A. Harada and Y. Ishizaka. 2011. Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specifi c chemotherapy. Biomaterials. 32: 1387-1395.
73. Kuempel, E.D. and C.L. Geraci and P.A. Schulte. 2012. Risk assessment and risk management of nanomaterials in the workplace: translating research to practice. Ann. Occup. Hyg. 56: 491-505.
74. Kumar, A. and F. Chen, A. Mozhi, X. Zhang, Y. Zhao, X. Xue, Y. Hao, X. Zhang, P.C. Wang and X.J. Liang. 2013. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale. 5: 8307-8325.
75. Kunzmann, A. and B. Andersson, T. Thurnherr, H. Krug, A. Scheynius and B. Fadeel. 2011. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim. Biophys. Acta. 1810: 361-373.
76. Kuznetsova, N.R. and C. Sevrin, D. Lespineux, N.V. Bovin, E.L. Vodovozova, T. Mészáros, J. Szebeni and C. Grandfi ls. 2012. Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. J. Control. Release. 160: 394-400.
77. Lamprecht, A. and H. Yamamoto, H. Takeuchi and Y. Kawashima. 2005. Nanoparticles enhance therapeutic effi ciency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther. 315: 196-202.
78. Laverman, P. and M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, N. van Rooijen, F.H. Corstens and G. Storm. 2001. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther. 298: 607-612.
79. Lazzari, S. and D. Moscatelli, F. Codari, M. Salmona, M. Morbidelli and L. Diomede. 2012. Colloidal stability of polymeric nanoparticles in biological fl uids. J. Nanopart. Res. 14: 920.
80. Lee, D.W. and S.A. Shirley, R.F. Lockey and S.S. Mohapatra. 2006. Thiolated chitosan nanoparticles enhance anti-infl ammatory effects of intranasally delivered theophylline. Respir. Res. 7: 112.
81. Li, C. and K. Yang, Y. Zhang, H. Tang, F. Yan, L. Tan, Q. Xie and S. Yao. 2011. Highly biocompatible multi-walled carbon nanotube-chitosan nanoparticle hybrids as protein carriers. Acta Biomater. 7: 3070-3077.
82. Lin, Y.L. and Y.K. Liu, N.M. Tsai, J.H. Hsieh, C.H. Chen, C.M. Lin and K.W. Liao. 2012. A lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. Nanomedicine. 8: 318-327.
83. Lin, Y.C. and L.Y. Lin, M.Y. Gao and Y.P. Fang. 2013. Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility. Int. J. Nanomedicine. 8: 3833-3842.
84. Liu, C. and F. Liu, L. Feng, M. Li, J. Zhang and N. Zhang. 2013a. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials. 34: 2547-2564.
85. Liu, T.Y. and M.Y. Wu, M.H. Lin and F.Y. Yang. 2013b. A novel ultrasound-triggered drug vehicle with multimodal imaging functionality. Acta Biomater. 9: 5453-5463.
86. Liu, J. and C. Detrembleur, A. Debuigne, M.C. De Pauw-Gillet, S. Mornet, L. Vander Elst, S. Laurent, C. Labrugère, E. Duguet and C. Jérôme. 2013c. Poly(acrylic acid)-block-poly(vinyl alcohol) anchored maghemite nanoparticles designed for multi-stimuli triggered drug release. Nanoscale. 5: 11464-11477.
87. Loh, X.J. and J. del Barrio, P.P. Toh, T.C. Lee, D. Jiao, U. Rauwald, E.A. Appel and O.A. Scherman. 2012. Triply triggered doxorubicin release from supramolecular nanocontainers. Biomacromolecules. 13: 84-91.
88. Lorenzato, C. and A. Cernicanu, M.E. Meyre, M. Germain, A. Pottier, L. Levy, B.D. de Senneville, C. Bos, C. Moonen and P. Smirnov. 2013. MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery. Contrast Media Mol. Imaging. 8: 185-192.
89. Lue, S.J. and B.W. Chen, C.M. Shih, F.Y. Chou, J.Y. Lai and W.Y. Chiu. 2013. Micron-and nanosized poly(N-isopropylacrylamide-co-acrylic acid) latex syntheses and their applications for controlled drug release. J. Nanosci. Nanotechnol. 13: 5305-5315.
90. Lv, C. and Z. Wang, P. Wang and X. Tang. 2012. Photodegradable polyurethane self-assembled nanoparticles for photocontrollable release. Langmuir. 28: 9387-9394.
91. Ma, P. and R.J. Mumper. 2013. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review. Nano Today. 8: 313-331.
92. Maeda, H. 2013. The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci. 104: 779-789.
93. Maeda, H. and G.Y. Bharate and J. Daruwalla. 2009. Polymeric drugs for effi cient tumortargeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 71: 409-419.
94. Maeda, H. and H. Nakamura and J. Fang. 2013. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65: 71-79.
95. Manconi, M. and A. Nácher, V. Merino, M. Merino-Sanjuan, M.L. Manca, C. Mura, S. Mura, A.M. Fadda and O. Diez-Sales. 2013. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. AAPS Pharm. Sci. Tech. 14: 485-496.
96. Marpu, S. and Z. Hu and M.A. Omary. 2010. Brightly phosphorescent, environmentally responsive hydrogels containing a water-soluble three-coordinate gold(I) complex. Langmuir. 26: 15523-15531.
97. Matsuo, Y. and T. Ishihara, J. Ishizaki, K. Miyamoto, M. Higaki and N. Yamashita. 2009. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol. 260: 33-38.
98. Md, S. and R.A. Khan, G. Mustafa, K. Chuttani, S. Baboota, J.K. Sahni and J. Ali. 2012. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model. Eur. J. Pharm. Sci. 48: 393-405.
99. Meissner, Y. and Y. Pellequer and A. Lamprecht. 2006. Nanoparticles in infl ammatory bowel disease: particle targeting versus pH-sensitive delivery. Int. J. Pharm. 316: 138-143.
100. Men, K. and W. Liu, L. Li, X. Duan, P. Wang, M. Gou, X. Wei, X. Gao, B. Wang, Y. Du, M. Huang, L. Chen, Z. Qian and Y. Wei. 2012. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Nanoscale. 4: 6425-6433.
101. Moazeni, E. and K. Gilani, F. Sotoudegan, A. Pardakhty, A.R. Najafabadi, R. Ghalandari, M.R. Fazeli and H. Jamalifar. 2010. Formulation and in vitro evaluation of ciprofl oxacin containing niosomes for pulmonary delivery. J. Microencapsul. 27: 618-627.
102. Moghimi, S.M. and A.C. Hunter and J.C. Murray. 2001. Long-circulating and target-specifi c nanoparticles: theory to practice. Pharmacol. Rev. 53: 283-318.
103. Mohammadi, G. and A. Nokhodchi, M. Barzegar-Jalali, F. Lotfipour, K. Adibkia, N. Ehyaei and H. Valizadeh. 2011. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids Surf. B Biointerfaces. 88: 39-44.
104. Moog, R. and A.M. Burger, M. Brandl, J. Schüler, R. Schubert, C. Unger, H.H. Fiebig and U. Massing. 2002. Change in pharmacokinetic and pharmacodynamic behaviour of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother. Pharmacol. 49: 356-366.
105. Moulari, B. and D. Pertuit, Y. Pellequer and A. Lamprecht. 2008. The targeting of surface modifi ed silica nanoparticles to infl amed tissue in experimental colitis. Biomaterials. 29: 4554-4560.
106. Nogueira, D.R. and L. Tavano, M. Mitjans, L. Pérez, M.R. Infante and M.P. Vinardell. 2013. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials. 34: 2758-2772.
107. Ong, H.X. and D. Traini, D. Cipolla, I. Gonda, M. Bebawy, H. Agus and P.M. Young. 2012. Liposomal nanoparticles control the uptake of ciprofl oxacin across respiratory epithelia. Pharm. Res. 29: 3335-3346.
108. Ortiz, R. and J. Prados, C. Melguizo, J.L. Arias, M.A. Ruiz, P.J. Alvarez, O. Caba, R. Luque, A. Segura and A. Aránega. 2012. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Int. J. Nanomedicine. 7: 95-107.
109. Park, S.J. and S.G. Choi, E. Davaa and J.S. Park. 2011. Encapsulation enhancement and stabilization of insulin in cationic liposomes. Int. J. Pharm. 415: 267-272.
110. Paulo, C.S. and M.M. Lino, A.A. Matos and L.S. Ferreira. 2013. Differential internalization of amphotericin B-conjugated nanoparticles in human cells and the expression of heat shock protein 70. Biomaterials. 34: 5281-5293.
111. Pertuit, D. and B. Moulari, T. Betz, A. Nadaradjane, D. Neumann, L. Ismaïli, B. Refouvelet, Y. Pellequer and A. Lamprecht. 2007. 5-amino salicylic acid bound nanoparticles for the therapy of infl ammatory bowel disease. J. Control. Release. 123: 211-218.
112. Pirollo, K.F. and E.H. Chang. 2008. Does a targeting ligand infl uence nanoparticle tumor localization or uptake? Trends Biotechnol. 26: 552-558.
113. Prüll, C.R. 2003. Part of a scientifi c master plan? Paul Ehrlich and the origins of his receptor concept. Med. Hist. 47: 332-356.
114. Rangger, C. and A. Helbok, E. von Guggenberg, J. Sosabowski, T. Radolf, R. Prassl, F. Andreae, G.C. Thurner, R. Haubner and C. Decristoforo. 2012. Infl uence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles. Int. J. Nanomedicine. 7: 5889-5900.
115. Rao, N.V. and S.R. Mane, A. Kishore, J. Das Sarma and R. Shunmugam. 2012. Norbornene derived doxorubicin copolymers as drug carriers with pH responsive hydrazone linker. Biomacromolecules. 13: 221-230.
116. Reddy, L.H. and J.L. Arias, J. Nicolas and P. Couvreur. 2012. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev. 112: 5818-5878.
117. Reix, N. and A. Parat, E. Seyfritz, R. Van der Werf, V. Epure, N. Ebel, L. Danicher, E. Marchioni, N. Jeandidier, M. Pinget, Y. Frère and S. Sigrist. 2012. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Int. J. Pharm. 437: 213-220.
118. Rejinold, N.S. and T. Baby, S.V. Nair and R. Jayakumar. 2013. Paclitaxel loaded fi brinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells. J. Biomed. Nanotechnol. 9: 1657-1671.
119. Reshetov, V. and H.P. Lassalle, A. François, D. Dumas, S. Hupont, S. Gräfe, V. Filipe, W. Jiskoot, F. Guillemin, V. Zorin and L. Bezdetnaya. 2013. Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfi n): comparison of treatment effi cacy and distribution characteristics in vivo. Int. J. Nanomedicine. 8: 3817-3831.
120. Rodrigues, H.F. and F.M. Mello, L.C. Branquinho, N. Zufelato, E.P. Silveira-Lacerda and A.F. Bakuzis. 2013. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform fi eld confi guration. Int. J. Hyperthermia. 29: 752-767.
121. Sabzevari, A. and K. Adibkia, H. Hashemi, A. Hedayatfar, N. Mohsenzadeh, F. Atyabi, M.H. Ghahremani and R. Dinarvand. 2013. Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies. Eur. J. Pharm. Biopharm. 84: 63-71.
122. Sahana, D.K. and G. Mittal, V. Bhardwaj and M.N. Kumar. 2008. PLGA nanoparticles for oral delivery of hydrophobic drugs: infl uence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J. Pharm. Sci. 97: 1530-1542.
123. Sakai, T. and T. Ishihara, M. Higaki, G. Akiyama and H. Tsuneoka. 2011. Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 52: 1516-1521.
124. Sánchez-Paradinas, S. and M. Pérez-Andrés, M.J. Almendral-Parra, E. Rodríguez-Fernández, A. Millán, F. Palacio, A. Orfao, J.J. Criado and M. Fuentes. 2013. Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles. J. Inorg. Biochem. 131C: 8-11.
125. Santos, D.P. and M.A. Ruiz, V. Gallardo, M.V.B. Zanoni and J.L. Arias. 2011. Multifunctional antitumor magnetite/chitosan-L-glutamic acid (core/shell) nanocomposites. J. Nanopart. Res. 13: 4311-4323.
126. Savla, R. and O. Taratula, O. Garbuzenko and T. Minko. 2011. Tumor targeted quantum dotmucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J. Control. Release. 153: 16-22.
127. Seju, U. and A. Kumar and K.K. Sawant. 2011. Development and evaluation of olanzapineloaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater. 7: 4169-4176.
128. Shao, W. and A. Paul, B. Zhao, C. Lee, L. Rodes and S. Prakash. 2013. Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials. 34: 10109-10119.
129. Sharma, G. and V. Kodali, M. Gaffrey, W. Wang, K.R. Minard, N.J. Karin, J.G. Teeguarden and B.D. Thrall. 2014. Iron oxide nanoparticle agglomeration infl uences dose rates and modulates oxidative stress-mediated dose-response profi les in vitro. Nanotoxicology. 8: 663-675.
130. Shen, J. and G. Song, M. An, X. Li, N. Wu, K. Ruan, J. Hu and R. Hu. 2014. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve effi cacy for non-small cell lung cancer therapy. Biomaterials. 35: 316-326.
131. Simpson, C.A. and B.J. Huffman and D.E. Cliffel. 2013. In vivo testing for gold nanoparticle toxicity. Methods Mol. Biol. 1026: 175-186.
132. Singh, R. and N.K. Mehra, V. Jain and N.K. Jain. 2013. Gemcitabine-loaded smart carbon nanotubes for effective targeting to cancer cells. J. Drug Target. 21: 581-592.
133. Sivasubramanian, M. and T. Thambi, V.G. Deepagan, G. Saravanakumar, H. Ko, Y.M. Kang and J.H. Park. 2013. Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin. J. Nanosci. Nanotechnol. 13: 7271-7278.
134. Snyder-Talkington, B.N. and Y. Qian, V. Castranova and N.L. Guo. 2012. New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics. J. Toxicol. Environ. Health B Crit. Rev. 15: 468-492.
135. Su, C.W. and S.Y. Chen and D.M. Liu. 2013. Polysaccharide-lecithin reverse micelles with enzyme-degradable triglyceride shell for overcoming tumor multidrug resistance. Chem. Commun. (Camb.). 49: 3772-3774.
136. Sun, J. and Q. Zhang, Z. Wang and B. Yan. 2013. Effects of nanotoxicity on female reproductivity and fetal development in animal models. Int. J. Mol. Sci. 14: 9319-9337.
137. Sun, T.M. and Y.C. Wang, F. Wang, J.Z. Du, C.Q. Mao, C.Y. Sun, R.Z. Tang, Y. Liu, J. Zhu, Y.H. Zhu, X.Z. Yang and J. Wang. 2014. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds. Biomaterials. 35: 836-845.
138. Takahama, H. and H. Shigematsu, T. Asai, T. Matsuzaki, S. Sanada, H.Y. Fu, K. Okuda, M. Yamato, H. Asanuma, Y. Asano, M. Asakura, N. Oku, I. Komuro, M. Kitakaze and T. Minamino. 2013. Liposomal amiodarone augments anti-arrhythmic effects and reduces hemodynamic adverse effects in an ischemia/reperfusion rat model. Cardiovasc. Drugs Ther. 27: 125-132.
139. Terreno, E. and F. Uggeri and S. Aime. 2012. Image guided therapy: the advent of theranostic agents. J. Control. Release. 161: 328-337.
140. Thakkar, H. and R. Kumar Sharma and R.S. Murthy. 2007. Enhanced retention of celecoxibloaded solid lipid nanoparticles after intra-articular administration. Drugs R D. 8: 275-285.
141. Tian, B. and W.T. Al-Jamal, K.T. Al-Jamal and K. Kostarelos. 2011. Doxorubicin-loaded lipidquantum dot hybrids: surface topography and release properties. Int. J. Pharm. 416: 443-447.
142. Torchilin, V. 2009. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur. J. Pharm. Biopharm. 71: 431-444.
143. Trapani, A. and E. De Giglio, D. Cafagna, N. Denora, G. Agrimi, T. Cassano, S. Gaetani, V. Cuomo and G. Trapani. 2011. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int. J. Pharm. 419: 296-307.
144. Türker, S. and S. Erdoğan, Y.A. Ozer, H. Bilgili and S. Deveci. 2008. Enhanced effi cacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis. J. Drug Target. 16: 51-57.
145. United States Government Accountability Office. 2010. United States Government Accountability Offi ce report on nanotechnology: nanomaterials are widely used in commerce, but EPA faces challenges in regulating risk. Int. J. Occup. Environ. Health. 16: 525-539.
146. Valizadeh, H. and G. Mohammadi, R. Ehyaei, M. Milani, M. Azhdarzadeh, P. Zakeri-Milani and F. Lotfipour. 2012. Antibacterial activity of clarithromycin loaded PLGA nanoparticles. Pharmazie. 67: 63-68.
147. Van de Ven, H. and C. Paulussen, P.B. Feijens, A. Matheeussen, P. Rombaut, P. Kayaert, G. Van den Mooter, W. Weyenberg, P. Cos, L. Maes and A. Ludwig. 2012. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome. J. Control. Release. 161: 795-803.
148. van der Meel, R. and L.J. Vehmeijer, R.J. Kok, G. Storm and E.V. van Gaal. 2013. Ligandtargeted particulate nanomedicines undergoing clinical evaluation: current status. Adv. Drug Deliv. Rev. 65: 1284-1298.
149. Vauthier, C. and K. Bouchemal. 2009. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 26: 1025-1058.
150. Vivek, K. and H. Reddy and R.S. Murthy. 2007. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS Pharm. Sci. Tech. 8: E83.
151. Wang, B. and Z. Wang, W. Feng, M. Wang, Z. Hu, Z. Chai and Y. Zhao. 2010. New methods for nanotoxicology: synchrotron radiation-based techniques. Anal. Bioanal. Chem. 398: 667-676.
152. Wang, Y. and B.B. Newell and J. Irudayaraj. 2012. Folic acid protected silver nanocarriers for targeted drug delivery. J. Biomed. Nanotechnol. 8: 751-759.
153. Xie, J. and K. Chen, J. Huang, S. Lee, J. Wang, J. Gao, X. Li and X. Chen. 2010. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials. 31: 3016-3022.
154. Yang, J. and S.B. Park, H.G. Yoon, Y.M. Huh and S. Haam. 2006. Preparation of poly ε-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int. J. Pharm. 324: 185-190.
155. Yang, Y.J. and X. Tao, Q. Hou and J.F. Chen. 2009. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen. Acta Biomater. 5: 3488-3496.
156. Yang, T. and H.H. Sheng, N.P. Feng, H. Wei, Z.T. Wang and C.H. Wang. 2013. Preparation of andrographolide-loaded solid lipid nanoparticles and their in vitro and in vivo evaluations: characteristics, release, absorption, transports, pharmacokinetics, and antihyperlipidemic activity. J. Pharm. Sci. 102: 4414-4425.
157. Yoo, D. and H. Jeong, S.H. Noh, J.H. Lee and J. Cheon. 2013. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia. Angew. Chem. Int. Ed. Engl. 52: 13047-13051.
158. Zhan, C. and X. Wei, J. Qian, L. Feng, J. Zhu and W. Lu. 2012. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. J. Control. Release. 160: 630-636.
159. Zhou, J. and Z. Lu, X. Zhu, X. Wang, Y. Liao, Z. Ma and F. Li. 2013. NIR photothermal therapy using polyaniline nanoparticles. Biomaterials. 34: 9584-9592.
160. Zhu, M. and G. Nie, H. Meng, T. Xia, A. Nel and Y. Zhao. 2013. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc. Chem. Res. 46: 622-631.